OPTIMAM Mammography Image Database: a large scale resource of
  mammography images and clinical data by Halling-Brown, Mark D et al.
OPTIMAM Mammography Image Database: a large 
scale resource of mammography images and clinical 
data 
Mark D Halling-Brown​1,2​, Lucy M Warren​1​, Dominic Ward​1​, Emma Lewis​1, 2​, Alistair 
Mackenzie​1​, Matthew G Wallis​3​, Louise Wilkinson​4​, Rosalind M Given-Wilson​5​, Rita 
McAvinchey​6​, Kenneth C Young​1,2 
 
1​Royal Surrey NHS Foundation Trust, Egerton Road, Guildford, GU2 7XX, UK 
2​University of Surrey, Guildford, GU2 7XH, UK  
3​Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge & NIHR 
Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, UK 
4​Oxford Breast Imaging Centre, Oxford University Hospitals NHS Foundation Trust, OX3 7LE, UK 
5​Department of Radiology, St George’s Healthcare NHS Trust, London, SW17 0QT, UK 
6​Jarvis Breast Screening Unit, Guildford, GU1 1LJ, UK 
 
Corresponding author details 
Dr Mark Halling-Brown, Royal Surrey NHS Foundation Trust, Egerton Road, Guildford, GU2 
7XX, UK +44(0)1483 571122 (Ext: 6876), ​mhalling-brown@nhs.net 
 
 
Abstract 
A major barrier to medical imaging research and in particular the development of artificial              
intelligence (AI) is a lack of large databases of medical images which share images with               
other researchers [1]. Without such databases it is not possible to train generalisable AI              
algorithms, and large amounts of time and funding is spent collecting smaller datasets at              
individual research centres. The OPTIMAM image database (OMI-DB) has been developed           
to overcome these barriers. OMI-DB consists of several relational databases and cloud            
storage systems, containing mammography images and associated clinical and pathological          
information. The database contains over 2.5 million images from 173,319 women collected            
from three UK breast screening centres. This includes 154,832 women with normal breasts,             
6909 women with benign findings, 9690 women with screen-detected cancers and 1888            
women with interval cancers. Collection is on-going and all women are followed-up and their              
clinical status updated according to subsequent screening episodes. The availability of prior            
screening mammograms and interval cancers is a vital resource for AI development. Data             
from OMI-DB has been shared with over 30 research groups and companies, since 2014.              
This progressive approach has been possible through sharing agreements between the           
funder and approved academic and commercial research groups. A research dataset such            
as the OMI-DB provides a powerful resource for research. 
 
Introduction  
The development of AI software products to improve the outcomes of breast screening is              
reliant on the availability of well-curated image databases [1]. The OPTIMAM Mammography            
Image Database (OMI-DB) [2, 3] was created to provide a centralized, fully annotated             
dataset for research. The initial reason for creating the database was to conduct research in               
the Cancer Research UK funded projects OPTIMAM (2008-2013) and OPTIMAM2          
(2013-2018) which evaluated how various factors affect breast cancer detection in           
mammograms. In the UK, the National Health Service Breast Screening Programme           
(NHSBSP) invites women to attend breast screening every three years between the ages of              
50 and 70. At some screening centres younger and older women are also invited for               
screening as part of the national age trial [4]. Some women in high-risk groups may receive                
annual invitations to screening. Our objective was to collect all mammograms for women             
with screen detected cancers at three screening centres (sites) as well as representative             
samples of normal and benign screening cases. This resource was designed to be shared              
for research purposes, most notably in Virtual Clinical Trials (VCT), Computer Aided            
Detection (CAD), artificial intelligence (AI), image perception studies, training and quality           
assurance.  
Image database: Image collection and design  
The processes and systems required to allow image collection are complex. Figure 1a             
shows a simplified view of the two types of image collection: ​automated remote-site and              
stand-alone​. A full description of the processes can be found in the Supplementary Material.              
The collection site’s clinical database, the National Breast Screening System (NBSS), is            
queried to identify a set of clients based on collection requirements, for example study-date              
range, outcome classification (Normal or Malignant), or high-risk status. Images and clinical            
data for the clients’ screening and assessment episodes are retrieved. For all the images              
currently in OMI-DB from three screening centres, this process has been fully automated             
using a physical or virtual server on site. However, tools have been developed and tested               
for future collection sites where setting up a server is not possible or feasible. In this                
stand-alone collection, the image collection tool is downloaded by a staff-member and            
pointed at a manually prepared folder containing images for collection, and the NBSS             
databases queried for clinical data for those clients. All further processing and storage of              
imaging and NBSS data follows the automated collection procedure​. 
 
Imaging and screening data is pseudonymised and records inserted into the clinical            
collection site’s lookup tables. Images, image meta-data and screening data are uploaded to             
the cloud for storage in a central database. All collection activity relating to clients, e.g.               
NBSS and PACS queries, and meta-data related to collection runs, is logged at the              
collection site. 
 
The OMI-DB is made up of several relational databases and cloud storage systems [3].              
Figure 1b shows an amalgamated, simplified schema of the data model. The associated             
data comprises radiological, clinical and pathological information extracted from the NBSS. 
 
 Figure 1a: simplified representation of processes for collecting and annotating imaging, clinical and 
ground truth data used to populate the OMI-DB  
 
Figure 1b: schema showing simplified data model for radiological (tables marked in blue), clinical and 
pathological (tables marked in green) and ground-truth (tables marked in orange) information stored in 
the OMI-DB  
 
  
When loading the images into the image database, all relevant DICOM tags are extracted to               
allow a searchable index to be produced. Information on screening history, previous            
occurrences of cancer, biopsy results and surgical procedures are collected from NBSS.            
The radiological location of lesions are not stored routinely in the clinical databases.             
However, such information is particularly useful for training and evaluating AI algorithms.            
This has been collected specifically for OMI-DB. Experienced mammography readers have           
drawn regions-of-interest indicating the location and area of lesions and other attributes,            
such as radiological appearance and conspicuity. 7143 lesions have been marked (including            
approximately 60% of screen-detected cancers). A web-enabled, remotely accessible         
software application has been developed which allows radiologists to view cases, annotate            
clinical features and participate in observer studies [5].  
 
Content of OMI-DB 
 
OMI-DB contains images and associated clinical data that has been collected since 2011             
from three UK screening sites - Jarvis Breast Screening Centre in Guildford, St George's              
Hospital in South West London and Addenbrookes Hospital in Cambridge.  
 
Screening mammograms for all screen-detected cancers and the prior screening          
mammograms of interval cancers since 2012 have been collected from the three screening             
sites. In addition, images and clinical data were collected for all women screened between              
1st January 2014 and 31st December 2014, and 25% of all women screened in 2012, 2013                
and 2015 were randomly selected for database inclusion. The total number of all types of               
images in the database is 2,889,312. 
 
The database contains unprocessed and processed images. Unprocessed images are          
essential for studies on image processing, and how the design parameters for imaging             
systems affect clinical performance and CAD. 
 
Table 1 provides the distribution of invasive status and grade for screen-detected cancers             
and interval cancers, calculated from the NBSS clinical annotations. Twenty          
screen-detected cancers and twelve interval cancers were excluded due to lack of            
information on invasive status and grade in the clinical databases. 
 
The availability of previous screening events and interval cancers opens up a wealth of              
potential research applications evaluating whether an abnormality could have been detected           
on the previous screening images via alterations to processing or perception. The number of              
women with 1, 2, 3 or more screening episodes with images in OMI-DB are shown in Figure                 
2. In addition to these episodes with images, OMI-DB contains clinical information for all              
episodes prior to when imaging systems at the clinical sites started using digital systems. 
 
Initially, collection was only for 2D digital mammography images, however as the collection             
has progressed we have included additional modalities: such as tomosynthesis and MRI. 
 
Table 1. Distribution of invasive status and grade, of screen-detected and interval cancers in OMI-DB  1
Invasive status Grade Screen detected cancers Interval cancers 
Invasive Grade 1 1593 148 
Grade 2 3518 610 
Grade 3 1212 408 
Not Assessable 39 6 
No grade 556 178 
In-situ 
 
Low grade 205 13 
Intermediate grade 673 36 
High grade 1205 56 
Not Assessable 0 0 
No grade 515 36 
TOTAL  9516 1491 
 
 
 
 
Figure 2. Number of women with 1, 2, 3 or more screening episodes with images in OMI-DB (a) 
Women with normal breasts (b) Women with interval cancers (c) Women with benign lesions (d) 
Women with screen-detected cancers 
1 For details of the classification procedures and source code used to generate the count data, visit 
https://bitbucket.org/scicomcore/omidb-2020 
 
Data Sharing  
The project has approval from an ethical research committee specializing in research            
databases organised by the NHS Health Research Agency. The funder (Cancer Research            
UK) retains the intellectual property of the database and implements sharing agreements            
with approved academic and commercial research groups. This is a progressive approach            
to data collection and centralization and benefits the wider scientific community by avoiding             
the need for each group to undertake the enormous task of collecting their own datasets.               
The sharing of images and metadata with external parties requires additional processes            
involving further de-identification. A dedicated database records cases that have been           
shared with each third-party. The database also keeps a record of the primary investigators              
for the third party and additional information pertinent to sharing. A dedicated download             
co-ordinating tool has been developed to facilitate secure transfer and regularly           
synchronizes the metadata defined by the access list. Researchers are encouraged to use             
our open-source Python package that parses the shared OMI-DB to provide a detailed API              
and tools to facilitate metadata extraction and filtering. For enquiries regarding accessing            
data and images from OMI-DB, contact the CRUK Commercial Partnerships Team or apply             
via the OMI-DB website [14]. 
 
Use of database 
The database has been used in many projects undertaken at the Royal Surrey NHS              
Foundation Trust [6-9]. This includes virtual clinical trials to investigate the effect of factors              
such as detector type, dose and image processing on breast cancer detection [8,9]. Finally,              
images and data from OMI-DB have been used to evaluate the cancer characteristics and              
breast density of women in the UK NHSBSP [7, 10]. 
 
The OMI-DB has been shared widely to many groups for a variety of research aims. The                
majority of the research has been to develop machine-learning techniques applied to            
mammography images. Selected data from the OMI-DB has been shared with over 30             
academic, research and commercial groups to train their AI algorithms. 
 
As well as for training AI algorithms, it has been possible to share independent images for                
evaluation of AI algorithms that have not been used for other purposes. Images and data               
have been used to evaluate several AI algorithms at different stages of development from              
prototypes to CE marked products available for purchase [11-13]. 
 
Discussion  
The difficulty and cost of setting up an annotated mammographic image database with             
sharing protocols should not be underestimated. Any collection process should ideally be            
automatic, link clinical data to the images, whilst retaining confidentiality and expert            
annotation. Developing such a system has been time consuming and challenging. Since            
2011, we have met these challenges and created a large database of images and              
associated data of the full range of cases acquired during breast screening. Collection into              
 
the database is ongoing and it is updated with any new information or subsequent screening               
episode for each case. Live updates on the data presented in Table 1 and Figure 2 are                 
provided at the OPTIMAM database website [14]. The database has sharing protocols that             
allow the images to be used by researchers around the world  [11-13].  
The availability of previous screening events and interval cancers opens up a wealth of              
potential AI research applications evaluating whether an abnormality could have been           
detected on the previous screening images. A research dataset such as the OMI-DB             
provides a powerful resource for research. The sequential normal cases can be analysed             
using quantitative imaging features, with a priori knowledge that some years later these             
cases develop a malignancy. 
Overall, a valuable, sharable database has been developed which holds both processed and             
unprocessed mammography images with annotated cancers and clinical details. 
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Supplemental Materials 
Website: ​https://medphys.royalsurrey.nhs.uk/omidb/ 
An open source Python API and command-line tool has been developed to facilitate and              
promote scientific research with OMI-DB. Project documentation can be found at           
https://scicomcore.bitbucket.io/omidb 
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